Shane Ward - 15 Mar 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: COO & CLO
Signature: /s/ Shane Ward
Issuer symbol: CDTX
Transactions as of: 15 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Mar 2024, 18:48:49 UTC
Previous filing: 12 Mar 2024
Next filing: 02 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+120,000	+60%	$0.000000	318,770	15 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+250,000		$0.000000	250,000	15 Mar 2024	Common Stock	250,000	$0.6849	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.